Evolent Health, Inc. (NYSE:EVH) Q1 2024 Earnings Call Transcript
Operator: Welcome to the Evolent Earnings Conference Call for the First Quarter Ended March 31, 2024. As a reminder, this conference call is being recorded.
Evolent Health Inc. (EVH)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | RA Capital Management Peter Kolchinsky | 5,736,132 | $188,087,768 | +126% | 2.39% |
| 2. | Rock Springs Capital Management Kris Jenner, Gordon Bussard, Graham Mcphail | 3,987,500 | $130,750,125 | +1% | 3.31% |
| 3. | Engaged Capital Glenn W. Welling | 3,261,458 | $106,943,208 | 17.32% | |
| 4. | Holocene Advisors Brandon Haley | 3,191,303 | $104,642,825 | +15% | 0.38% |
| 5. | OrbiMed Advisors Samuel Isaly | 2,605,615 | $85,438,116 | -6% | 1.56% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $6.73 | 14,749 | Officer, Director | 157,976 | 2019-12-04 | Filing | |
| $6.51 | 35,000 | Officer, Director | 623,655 | 2019-12-03 | Filing | |
| $7.04 | 7,200 | Director | 39,235 | 2019-08-15 | Filing | |
| $12.45 | 10,000 | Director | 38,212 | 2019-03-11 | Filing | |
| $7.03 | 15,000 | Director | 67,368 | 2019-08-09 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $27.25 | 20,900 | Officer, Director | 637,645 | 2023-12-05 | Filing | |
| $26.61 | 92,616 | Officer, Director | 658,545 | 2023-12-05 | Filing | |
| $25.74 | 27,484 | Officer, Director | 751,161 | 2023-12-05 | Filing | |
| $30.00 | 3,000 | Officer | 198,333 | 2023-11-15 | Filing | |
| $30.00 | 4,000 | Officer | 198,333 | 2023-11-15 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 12,890,729 | $425,780,779 | 0.03% | |
| 2. | 10,821,331 | $357,428,563 | 0% | |
| 3. | 8,424,802 | $278,271,210 | 0% | |
| 4. | 8,313,157 | $274,583,576 | 0.05% | |
| 5. | 5,917,684 | $195,461,101 | 0.02% |
News See All
Evolent Health, Inc. (NYSE:EVH) Q4 2023 Earnings Call Transcript
Operator: Welcome to the Evolent Earnings Conference Call for the Quarter and Year-Ended December 31, 2023. As a reminder, this conference call is being recorded.
Evolent Health, Inc. (NYSE:EVH) Q3 2023 Earnings Call Transcript
Operator: Welcome to the Evolent Earnings Conference Call for the quarter ended September 30th, 2023. As a reminder, this conference call is being recorded.
Billionaire Ray Dalio's 15 Best Stock Picks
While Ray Dalio gave up active leadership position of his hedge fund Bridgewater Associates to a new generation of fund managers, he still has a significant say on investment ideas owing to his position...
Evolent Health, Inc. (NYSE:EVH) Q2 2023 Earnings Call Transcript
Operator: Welcome to the Evolent Earnings Conference Call for the Quarter Ending June 30, 2023. As a reminder, this conference call is being recorded.
Evolent Health, Inc. (NYSE:EVH) Q1 2023 Earnings Call Transcript
Operator: Welcome to Evolent Health's Earnings Conference Call for the Quarter Ended March 31, 2023. As a reminder, this conference call is being recorded.
Evolent Health, Inc. (NYSE:EVH) Q4 2022 Earnings Call Transcript
Operator: Welcome to Evolent Health's Earnings Conference Call for the Fourth Quarter and Year ended December 31, 2022. As a reminder, this conference call is being recorded.
5 High Growth Healthcare Stocks to Buy
Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) is one of the high growth healthcare companies that is working on treatments for neuropsychiatric and neurologic disorders.
Here's Why Evolent Health (EVH) Declined in Q4
Carillon Tower Advisers, an investment management company, released its “Carillon Eagle Small Cap Growth Fund” fourth quarter 2022 investor letter. A copy of the same can be downloaded here.
Ray Dalio Stock Portfolio Q3 2022: Top 10 Small-Cap Stocks
In this article, we discuss the top 10 small-cap stocks from Ray Dalio’s Q3 2022 portfolio.
Billionaire Hedge Funds
